Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2025-12-24 @ 4:56 PM
NCT ID:
NCT01840150
Eligibility Criteria:
Inclusion Criteria:
* Patients must either have histologic or pathologically confirmed non-small cell lung cancer (NSCLC) or suspicious nodules/lesions which are going to be surgically resected before they are pathologically confirmed
* Patients must have stage I or II disease based on the parameters for staging NSCLC found in the American Joint Committee on Cancer (AJCC) cancer staging handbook seventh edition
* Patients must be deemed to be eligible candidates for either surgery or stereotactic radiation
* Stereotactic radiation treatment of stage I disease or adjuvant chemotherapy is allowed at the discretion of treating physician for the participating subject
* Patients who will have surgical resections must consent to the use of post-surgery tumor samples for correlative molecular studies
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
* Ability to travel to appointments and willingness to participate in this study
* Ability to understand and willingness to sign a consent and Health Insurance Portability and Accountability Act (HIPAA) authorization form
Exclusion Criteria:
* Patients who have had a prior lung cancer within the last five years from the current diagnosis
* Patients having a prior malignancy within the past 3 years other than resected of basal or squamous cell carcinoma of the skin, any in situ malignancy, or low-risk prostate cancer after curative therapy
* Patients with any prior systemic therapy for the current diagnosis of lung cancer
* Patients with a diagnosis of advanced stage disease (stage III or IV)
* Patients who are unable to comply with study and/or follow up procedures
* Patients who have uncontrolled intercurrent illness including, but not limited to psychiatric illness/social situations that would limit compliance with study requirements
* Patients who are pregnant or are breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01840150
Study Brief:
Protocol Section:
NCT01840150